<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Manuel Mastel</submitter><organism>Mus musculus</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-17076</full_dataset_link><description>Mice of the genetic background VBPN, VBPNA, VBPNC were injected with tamoxifen systemically (VBPN) or with 4-OHT intra-colonically (VBPNA, VBPNC). After tumor development, the material was processed and RNA-sequencing was conducted.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Library Construction - Whole-transcriptome sequencing libraries were prepared using a modified SMART-seq2-based workflow. Reverse transcription was carried out using 1 µM template-switching oligo (IDT), 1 mM dithiothreitol (Takara Bio Clontech, #707265ML), 1 U/µl RNase inhibitor (Promega, #N2615), Maxima H Minus Reverse Transcriptase (Thermo Fisher/Life Technologies, #EP0753), and 1× Maxima H Minus Reverse Transcriptase buffer. The resulting cDNA was tagmented and further processed for sequencing library generation using the Nextera XT DNA Library Preparation Kit (Illumina, #FC-121-1030).</sample_protocol><sample_protocol>Nucleic Acid Extraction - RNA was extracted from tumor and organoid samples using the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen, #74106). RNA quantity and integrity were evaluated on an Agilent Bioanalyzer using the Agilent RNA Kit (#5067-1513).</sample_protocol><sample_protocol>Sequencing - Next generation sequencing was performed at the German Cancer Research Center Sequencing Facility using an Illumina NovaSeq 6000 SP instrument.</sample_protocol><sample_protocol>Sample Collection - Tumors were collected by surgical excision from the colon or small intestine of mice.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Data Transformation - Raw paired-end RNA-seq reads were provided as gzipped FASTQ files. Sequencing quality was assessed using standard FASTQ quality-control metrics, and adapter sequences and low-quality bases were removed where necessary. Reads were aligned to the mouse reference genome using the splice-aware aligner STAR together with the corresponding gene annotation. Gene-level read counts were generated from the aligned reads using featureCounts. The resulting raw gene count matrix was normalized for sequencing depth and library composition using DESeq2 size-factor normalization. Normalized counts were used for quality control, sample clustering, and visualization, while differential expression analysis was performed using raw gene counts within the DESeq2 framework.</data_protocol><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Illumina NovaSeq 6000</instrument_platform><study_type>RNA-seq of coding RNA</study_type><species>Mus musculus</species><pubmed_authors>Manuel Mastel</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq of mouse tumors from the intestinal tract of mice with genetic background VBPN, VBPNA or VBPNC</name><description>Mice of the genetic background VBPN, VBPNA, VBPNC were injected with tamoxifen systemically (VBPN) or with 4-OHT intra-colonically (VBPNA, VBPNC). After tumor development, the material was processed and RNA-sequencing was conducted.</description><dates><release>2026-06-11T00:00:00Z</release><modification>2026-06-11T01:00:44.174Z</modification><creation>2026-05-26T10:55:51.153Z</creation></dates><accession>E-MTAB-17076</accession><cross_references><ENA>ERP193818</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>